Abstract |
Previous studies have demonstrated that lycopene possesses anti-inflammatory properties in the central nervous system. However, the potential role and the molecular mechanisms of lycopene in lipopolysaccharide (LPS)-challenge inflammation and depression-like behaviors has not been clearly investigated. The present study aimed to assess the effects and the potential mechanisms of lycopene on LPS-induced depression-like behaviors. Lycopene was orally administered (60mg/kg) every day for seven days followed by intraperitoneal LPS injection (1mg/kg). The Forced swim test and tail suspension test were used to detect changes in the depression-like behaviors. ELISA was used to measure the expression of interleukin-6 (IL-6) and tumor necrosis factor-α(TNF-α) in the plasma. Immunoblotting was performed to measure the expression of interleukin-1β (IL-1β) and heme oxygenase-1 (HO-1) in the hippocampus. The results showed that pretreatment with lycopene could ameliorate depression-like behaviors. Moreover, lycopene relieved neuronal cell injury in hippocampal CA1 regions. Furthermore, lycopene decreased LPS-induced expression of IL-1β and HO-1 in the hippocampus together with decreasing level of IL-6 and TNF-α in the plasma. Taken together, these results suggest that lycopene can attenuate LPS-induced inflammation and depression-like behaviors, which may be involved in regulating HO-1 in the hippocampus.
|
Authors | Fang Zhang, Yanyan Fu, Xiaoyan Zhou, Wei Pan, Yue Shi, Mei Wang, Xunbao Zhang, Dashi Qi, Lei Li, Kai Ma, Renxian Tang, Kuiyang Zheng, Yuanjian Song |
Journal | Journal of neuroimmunology
(J Neuroimmunol)
Vol. 298
Pg. 1-8
(09 15 2016)
ISSN: 1872-8421 [Electronic] Netherlands |
PMID | 27609268
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Elsevier B.V. All rights reserved. |
Chemical References |
- Antioxidants
- Interleukin-6
- Lipopolysaccharides
- Tumor Necrosis Factor-alpha
- Carotenoids
- Heme Oxygenase-1
- Lycopene
|
Topics |
- Animals
- Antioxidants
(therapeutic use)
- Carotenoids
(therapeutic use)
- Depression
(blood, drug therapy, etiology)
- Encephalitis
(chemically induced, complications)
- Enzyme-Linked Immunosorbent Assay
- Gene Expression Regulation
(drug effects)
- Heme Oxygenase-1
(metabolism)
- Hippocampus
(drug effects, metabolism)
- Interleukin-6
(blood)
- Lipopolysaccharides
(toxicity)
- Lycopene
- Mice
- Mice, Inbred ICR
- Tumor Necrosis Factor-alpha
(blood)
|